Vidacare Corporation

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Vidacare Corporation sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials none currently recruiting 9 completed top decile by trial count

Vidacare Corporation: 11 sponsored US clinical trials, none currently recruiting.

Vidacare Corporation sponsors 11 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 9 completed. The most-studied condition in this pipeline is Intraosseous Vascular Access, with 2 trials.

Top-decile sponsor footprint

Vidacare Corporation ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 44/100

9 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

11 total, page 1 of 1

COMPLETED NA

Comparing Powered Ported Bone Marrow Aspiration to Manual Standard Bone Marrow Aspiration Procedures

NCT02299102
COMPLETED NA

Continuous Intraosseous Vascular Access Over 48 Hours

NCT01866475
COMPLETED NA

Proximal Humerus Site for Anesthesia

NCT01866514
COMPLETED NA

Follow-Up Study Validating a Blended Technique to Identify the Proximal Humerus Intraosseous Vascular Access Site

NCT01866501
COMPLETED NA

Healthy Adult Volunteer Study of Intraosseous Infusion Using the Sternum

NCT01853215
COMPLETED NA

Evaluation of Various Methods Used to Identify the Proximal Humerus Intraosseous Vascular Access Site

NCT01742780
COMPLETED NA

A Study Comparing Use of Manual and Power Bone Marrow Aspiration and Biopsy Devices in Children

NCT02159118
TERMINATED

Observational Study of CT Dye Administration Through the Intraosseous Vascular Access Route

NCT01531686
TERMINATED

Observational Study of Rapid Sequence Intubation Drug Delivery Using Intraosseous and Intravenous Access.

NCT01486407
COMPLETED

Observation of Intraosseous Vascular Access in the Emergency Department

NCT01235078
COMPLETED NA

Powered Bone Marrow Aspiration and Core Biopsy System Compared to Manual Devices

NCT01312519

Therapeutic Areas

Intraosseous Vascular Access 2

How the Vidacare Corporation archive is shaped

11 indexed studies, none listed as recruiting (0% open); 9 completed (82%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Intraosseous Vascular Access (2 trials), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Vidacare Corporation: archived-pipeline peers nationwide

Peers matched on 11 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Vidacare Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share Vidacare CorporationAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiome10xBio22nd Century Group23andMe3-C Institute for Social Development
Vidacare Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Vidacare Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Vidacare Corporation page

11 registered trials is a research-attention snapshot, not an endorsement of Vidacare Corporation or any single study.

  • None of Vidacare Corporation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Intraosseous Vascular Access is the condition Vidacare Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Intraosseous Vascular Access trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Vidacare Corporation pipeline card: 11 registered trials from official public datasets.Report a data error.